E78.1

Applicable To

• Elevated fasting triglycerides

• Endogenous hyperglyceridemia

• Fredrickson’s hyperlipoproteinemia, type IV

• Hyperlipidemia, group B

• Hyperprebetalipoproteinemia

• Very-low-density-lipoprotein-type [VLDL] hyperlipoproteinemia

Approximate Synonyms

• Hyperlipoproteinemia, type i

• Hypertriglyceridemia

• Hypertriglyceridemia high blood fats)

• Hypertriglyceridemia, endogenous

• Hypertriglyceridemia, primary

• Primary hypertriglyceridemia

Clinical Information

• A hypertriglyceridemia disorder, often with autosomal dominant inheritance. It is characterized by the persistent elevations of plasma triglycerides, endogenously synthesized and contained predominantly in very-low-density lipoproteins pre-beta lipoproteins). In contrast, the plasma cholesterol and phospholipids usually remain within normal limits.

• Characterized by an isolated elevation in the plasma level of endogenously synthesized triglyceride carried in vldl; considered to be an autosomal dominant trait.

Details

• E78.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

• The 2023 edition of ICD-10-CM E78.1 became effective on October 1, 2022.

• This is the American ICD-10-CM version of E78.1 – other international versions of ICD-10 E78.1 may differ.